Efficacy and safety of Apremilast in Japanese patients with moderate to severe psoriasis: 68-week results from a phase 2b randomized trial
| Autor: | Shinichi Imafuku, Mayumi Komine, Yukari Okubo, Osamu Nemoto, Mamitaro Ohtsuki, Robert M. Day, Peng Chen, Allan Maroli |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
business.industry Moderate to severe psoriasis Dermatology 030226 pharmacology & pharmacy Biochemistry law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Internal medicine medicine Apremilast business Molecular Biology 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Journal of Dermatological Science. 86:e8 |
| ISSN: | 0923-1811 |
| DOI: | 10.1016/j.jdermsci.2017.02.022 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect